These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 28068461)

  • 21. Clinical differences between early and late remission in depressive patients.
    Roca M; García-Toro M; García-Campayo J; Vives M; Armengol S; García-García M; Asensio D; Gili M
    J Affect Disord; 2011 Nov; 134(1-3):235-41. PubMed ID: 21676465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adding smartphone-based cognitive-behavior therapy to pharmacotherapy for major depression (FLATT project): study protocol for a randomized controlled trial.
    Watanabe N; Horikoshi M; Yamada M; Shimodera S; Akechi T; Miki K; Inagaki M; Yonemoto N; Imai H; Tajika A; Ogawa Y; Takeshima N; Hayasaka Y; Furukawa TA;
    Trials; 2015 Jul; 16():293. PubMed ID: 26149441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.
    Aaronson ST; Sears P; Ruvuna F; Bunker M; Conway CR; Dougherty DD; Reimherr FW; Schwartz TL; Zajecka JM
    Am J Psychiatry; 2017 Jul; 174(7):640-648. PubMed ID: 28359201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges of Treatment-resistant Depression.
    Pandarakalam JP
    Psychiatr Danub; 2018 Sep; 30(3):273-284. PubMed ID: 30267518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study.
    Balestri M; Calati R; Souery D; Kautzky A; Kasper S; Montgomery S; Zohar J; Mendlewicz J; Serretti A
    J Affect Disord; 2016 Jan; 189():224-32. PubMed ID: 26451508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective Longitudinal Study of Predictors of Postpartum-Onset Depression in Women With a History of Major Depressive Disorder.
    Suri R; Stowe ZN; Cohen LS; Newport DJ; Burt VK; Aquino-Elias AR; Knight BT; Mintz J; Altshuler LL
    J Clin Psychiatry; 2017; 78(8):1110-1116. PubMed ID: 28297589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of Supplementary Cognitive-Behavioral Therapy for Pharmacotherapy-Resistant Depression: A Randomized Controlled Trial.
    Nakagawa A; Mitsuda D; Sado M; Abe T; Fujisawa D; Kikuchi T; Iwashita S; Mimura M; Ono Y
    J Clin Psychiatry; 2017; 78(8):1126-1135. PubMed ID: 28252882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING).
    Pettorruso M; Guidotti R; d'Andrea G; De Risio L; D'Andrea A; Chiappini S; Carullo R; Barlati S; Zanardi R; Rosso G; De Filippis S; Di Nicola M; Andriola I; Marcatili M; Nicolò G; Martiadis V; Bassetti R; Nucifora D; De Fazio P; Rosenblat JD; Clerici M; Maria Dell'Osso B; Vita A; Marzetti L; Sensi SL; Di Lorenzo G; McIntyre RS; Martinotti G;
    Psychiatry Res; 2023 Sep; 327():115378. PubMed ID: 37574600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of remission in 208 drug-resistant depressive patients treated with electroconvulsive therapy.
    Medda P; Mauri M; Toni C; Mariani MG; Rizzato S; Miniati M; De Simone L; Perugi G
    J ECT; 2014 Dec; 30(4):292-7. PubMed ID: 24625706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
    Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
    J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early response and remission as predictors of a good outcome of a major depressive episode at 12-month follow-up: a prospective, longitudinal, observational study.
    Ciudad A; Álvarez E; Roca M; Baca E; Caballero L; García de Polavieja P; Casillas M; Valladares A; Gilaberte I
    J Clin Psychiatry; 2012 Feb; 73(2):185-91. PubMed ID: 22053897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of a three-phase treatment algorithm for inpatients with melancholic depression.
    Vermeiden M; Kamperman AM; Hoogendijk WJG; van den Broek WW; Birkenhäger TK
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):214-220. PubMed ID: 29505804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Predictors of remission from major depressive disorder in secondary care].
    Salvo L; Saldivia S; Parra C; Cifuentes M; Bustos C; Acevedo P; Díaz M; Ormazabal M; Guerra I; Navarrete N; Bravo V; Castro A
    Rev Med Chil; 2017 Dec; 145(12):1514-1524. PubMed ID: 29652947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores.
    Ruhé HG; Dekker JJ; Peen J; Holman R; de Jonghe F
    Compr Psychiatry; 2005; 46(6):417-27. PubMed ID: 16275208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of treatment-resistant depression.
    Keitner GI; Mansfield AK
    Psychiatr Clin North Am; 2012 Mar; 35(1):249-65. PubMed ID: 22370501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying Remission From Depression on 3 Self-Report Scales.
    Zimmerman M; Walsh E; Friedman M; Boerescu DA; Attiullah N
    J Clin Psychiatry; 2017 Feb; 78(2):177-183. PubMed ID: 28234434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Considering Eligibility for Studies of Deep Brain Stimulation for Treatment-Resistant Depression: Insights From a Clinical Trial in Unipolar and Bipolar Depression.
    Filkowski MM; Mayberg HS; Holtzheimer PE
    J ECT; 2016 Jun; 32(2):122-6. PubMed ID: 26479487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.